Assessing and improving the resilience of bioinformatics pipelines to data errors
- Institution
- UNIV OF MARYLAND, COLLEGE PARK, MD
- Principal investigator
- Mihai Pop
- Funding
- $609K
- Duration
- 2025–2028
Moonbase score
Still being scored
Abstract
Project summary Despite significant investments in data curation, errors and other analytical artifacts abound in public biological databases. Such errors can have an important impact on bioinformatics software, leading to analytical errors. In certain applications, such as diagnostics or other clinical settings, such analytical errors can have important consequences. The speed of data generation has far outpaced the speed with which biologists can experimentally characterize molecules and organisms, or curate computer-generated annotations. Simply put, errors cannot be eliminated in a practically-meaningful way. Furthermore, the problems induced by low data quality are not always apparent and, thus, can be overlooked by practitioners, even if they are experts in their own field. This project aims to develop a better understanding of how data interact with the algorithms used in bioinformatics research to create the potential for the analytical errors. This understanding will also lead to the development of algorithms and strategies that are able to protect analytical results from errors in the reference data or in the input provided to the analysis.
LOADING MOONBASE SCORE
Questions for UNIV OF MARYLAND, COLLEGE PARK
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same researchers, same institution, same topic, scored first.
- NIH · Univ of Maryland, College ParkNot yet scored
Algorithms and Software for the Assembly of Metagenomic Data
Mihai Pop · $2.8M · 2013–2029
- NIH · Univ of Maryland, College Park46
Manipulation of the host cell inflammasome by Mycobacterium tuberculosis
Volker Briken · $593K · 2021–2027
- NIH · Univ of Maryland, College ParkNot yet scored
Engineering bacterial multicellular structures for therapeutic applications
Sara Molinari · $382K · 2025–2030